Abstract
globally in 2012 (3) . Therefore, the mechanisms of LC development and progression should be determined. Peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (PIN1) functions in the occurrence and metastasis of NSCLC, and thus may be a predictor for poor prognosis and a therapeutic target for the disease (4, 5) . The oncoprotein cancerous inhibitor of protein phosphatase 2A (CIP2A) is highly expressed in NSCLC, and is related to unfavorable prognosis and tumor cell proliferation (6, 7) . In addition, the overexpression of Zonula Occludens-1 (ZO-1, gene symbol TJP1) contributes to the good prognosis of patients with NS-CLC (8) . Furthermore, upregulated expression of micro RNA (miRNA) miR-21, and downregulated expression of miR-143 and miR-181a were detected in LC tissues, indicating that these miRNAs might be potential diagnostic or prognostic factors for the patients with NSCLC (9) . Although the above studies have reported some genes and miRNAs that correlated with LC, the pathogenesis of the disease remains unclear. In 2013, Rousseaux et al. developed an approach to explore the malignant epigenetic reprogramming of LC and identified a series of candidate cancer biomarkers (10) . However, they did not fully reveal the prognosis-associated genes in LC using bioinformatic analyses. In the present study, using the microarray data of Rousseaux et al. (10) , the prognostic mechanisms of LC were studied through differential expression analysis, enrichment analysis, mRNA-target prediction, protein-protein interaction (PPI) network analysis, and survival analysis.
Materials and Methods

Microarray data
The gene expression profile GSE30219 (https:// www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30219) was extracted from the Gene Expression Omnibus (GEO) database, which was sequenced on the platform of GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array. GSE30219 contained data for 293 LC samples and 14 normal lung samples.
Ethics approval and consent to participate
This study was approved by Ethics Committee of the General Hospital of Pingmei Shenma Medical Group.
Differential expression analysis and enrichment analysis
Using the Robust Multichip Average (RMA) algorithm (11) , normalization and gene expression calculations were conducted for the original data. The top 50 LC samples with the longest or the shortest postoperative follow-up times, respectively, were classified into good and poor prognosis groups. To identify prognosis-associated genes, the differentially expressed genes (DEGs) between the good and poor prognosis groups were analyzed using the Limma (http://www.bioconductor.org/packages/release/bioc/html/limma.html) package (12) in the R software. The screening criteria were set as |log fold change (FC)| > 0.58 and adjusted p-value < 0.05. Using the Database for Annotation, Visualization and Integrated Discovery (DAVID, https://david.ncifcrf.gov/) tool (13), the significant Kyoto Encyclopedia of Genes and Genomes (KEGG) (14) pathways involving the DEGs were identified.
Prediction of miRNAs targeting the DEGs
MiRNAs can regulate the transcription levels of target genes by binding with their 3' untranslated regions (15) . Therefore, the dysregulated expression of the DEGs might also be caused by miRNA regulation. The web-based gene set analysis toolkit (Webgestalt, http://www.webgestalt.org) tool (16) was used to predict the miRNAs that target the upregulated and downregulated genes.
Protein-protein interaction network analysis
The DEGs were submitted to the Search Tool for the Retrieval of Interacting Genes (STRING, http://string-db.org/) database (17) , and the PPIs with combined scores > 0.4 were selected. Subsequently, the PPI network was built using Cytoscape software (http://www.cytoscape.org) (18) and the clusterMaker plug-in (19) in Cytoscape was used to identify the significant network modules. The module nodes were then identified using Gene Ontology (GO) (20) functional enrichment analysis using the BinGO plug-in (21) in Cytoscape.
Survival analysis
Using the Survminer (22) and Survival (23) packages in R, survival analysis for the key genes was carried out. Based on the gene expression value, survival time, and survival state, the Survminer package could divide the samples into high expression and low expression groups. After grouping, survival analysis was conducted using the Survival package and a survival curve was drawn.
Validation using an independent dataset
The expression profile data for LC was downloaded from The Cancer Genome Atlas (TCGA) database, which included 502 LC samples and 49 normal samples. Based on the probe annotation file, the probes were mapped into gene symbols. More than one probe might correspond to the same gene symbol; therefore, their average value was calculated as the gene expression value. Differential expression analysis was then conducted using the R package, edgeR (24) (http://www.bioconductor.org/packages/ release/bioc/html/edgeR.html), with the thresholds of |logFC| > 0.58 and adjusted p-value < 0.05. Using the VENNY tool (http://bioinfogp. cnb.csic.es/tools/venny/index.html) (25) , the DEGs for GSE30219 and the TCGA dataset were compared to obtain the intersecting genes.
Results
Differential expression analysis and enrichment analysis
The top 50 LC samples with the longest (average follow-up time = 100.5 months) or the shortest (average follow-up time = 5.7 months) postoperative follow-up time were divided into good and poor prognosis groups, respectively. There were 518 DEGs (319 upregulated and 199 downregulated) in the two groups. KEGG pathway enrichment analysis suggested that the upregulated genes were significantly involved in the cell cycle. However, the downregulated genes had no significantly enriched pathways.
Prediction of miRNAs targeting the DEGs
Multiple miRNAs were predicted to target the upregulated and downregulated genes. The upregulated genes were mainly targeted by miR-190, miR-493, and miR-218 (Table 1A) . Meanwhile, the downregulated genes were mainly targeted by miR-302, miR-200, and miR-26 (Table  1B) .
PPI network analysis
For the DEGs, a PPI network (involving 110 upregulated and 39 downregulated genes) was built. Subsequently, three network modules (module 1, 2, and 3) were obtained in which the core nodes were cyclin-dependent kinase 1 (CDK1), minichromosome maintenance 10 (MCM10), and NDC80 kinetochore complex component (NDC80), respectively ( Figure 1) . In module 1, CDK1 could interact with both cyclin B1 (CCNB1) and cyclin B2 (CCNB2). GO functional enrichment analysis indicated that the module nodes were enriched in the M phase of the mitotic cell cycle (module 1, p-value = 4.91E-24), DNA replication (module 2, p-value = 4.44E-13), and M phase (module 3, p-value = 1.21E-13) ( Table 2) . 
Survival analysis
After the samples in GSE30219 were divided into high expression and low expression groups, survival analysis for CDK1, CCNB1, CCNB2, MCM10, and NDC80 was performed. The survival curves showed that the expression in all five genes correlated with the survival of patients with LC (p-value < 0.0001) (Figure 2 ).
Validation using an independent dataset
For the TCGA dataset, a total of 15226 DEGs were obtained. After comparing the DEGs for GSE30219 and the TCGA dataset, 412 intersecting genes (including CDK1, CCNB1, CCNB2, MCM10, and NDC80) were identified ( Figure 3 ).
Discussion
In this study, 518 DEGs in the good and poor prognosis groups were screened. marker for gastric cancer (26) . Downregulated expression of miR-190 inhibits the metastasis of breast cancer via inversely regulating the expression of SMAD family member 2 (SMAD2), which is correlated with the prognosis of patients with breast cancer (27) . By targeting integrin, beta 1 (ITGB1), miR-493-5p plays a prognostic role in NSCLC and could be used to diagnose the disease (28) . Four upregulated miRNAs and two downregulated miR- NAs (including miR-218-5p) were identified in lung adenocarcinoma (LUAD) tissues and may represent promising diagnostic and prognostic markers for patients with LUAD (29) . Overexpression of miR-200c plays an oncogenic role in NSCLC and correlates markedly with adverse prognosis; thus, it may serve as a prognostic biomarker for patients with NS-CLC (30). Exosome-derived miR-302b mediates the transforming growth factor beta (TGF beta RII)/ extracellular signal-regulated kinase (ERK) pathway, which can inhibit cell proliferation and migration in LC (31) . Therefore, , and miR-302 might affect the prognosis of LC by regulating the expression of the DEGs. CDK1 and MAD2 mitotic arrest deficient-like 1 (MAD2L1) can lead to high risk of recurrence and poor prognosis of patients with LUAD; therefore, they are negatively correlated with prognosis and may be promising therapeutic targets for the disease (32) . CCNB1 and CDK1 levels are higher in LC compared with those in normal tissues, and their expression levels vary among different types of LC (33, 34) . CCNB1 and cyclin A (CCNA) have dysregulated expression in NSCLC, and CCNB1 may serve as a potential prognostic factor for patients with NSCLC (35) . CCNB2 is overexpressed in LUAD cells, which independently predicts poor survival of patients with LUAD (36). CDK1 was predicted to interact with both CCNB1 and CCNB2 in module 1, suggesting that CDK1 might affect the prognosis of LC via interactions with CCNB1 and CCNB2. Minichromosome maintenance (MCM) proteins are involved in multiple cancers. In particular, MCM5 and MCM7 are independent prognostic markers for patients with LC (37, 38) . MCM4 is highly expressed in NSCLC and is related to non-adenocarcinoma histology, indicating that it might represent a therapeutic target in NS-CLC (39) . MCM2, MCM3, MCM7, MCM10, polo-like kinase 1 (PLK1), and S-phase kinase associated protein 2 (SKP2) are involved in cancer-associated pathways and may coordinately facilitate cell cycle-associated processes in tumors (40) . Cell division associated 1 (CDCA1) and NDC80 (also called KNTC2) are simultaneously upregulated in LC, which is a critical feature of tumor cell growth and survival and provides a valuable therapeutic strategy for the disease (41) . Therefore, our results, and those of previous studies, demonstrated that MCM10 and NDC80 might also be related to LC prognosis.
Although multiple bioinformatic methods were used to explore the prognostic mechanisms of LC, this study had several limitations. The lack of experimental validation was the most prominent limitation. Therefore, further experimental research is needed to support these results.
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